| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sharma A et al. | Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients. | 2013 | J Med Econ | pmid:23834479 |
| Hojs N et al. | Paricalcitol reduces proteinuria in non-dialysis chronic kidney disease patients. | 2013 | Ther Apher Dial | pmid:23931873 |
| Chen B et al. | Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects. | 2013 | Bioorg. Med. Chem. Lett. | pmid:24035340 |
| Amer H et al. | Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial. | 2013 | Am. J. Transplant. | pmid:23601186 |
| Duplancic D et al. | The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection. | 2013 | Clin Interv Aging | pmid:23430986 |
| Axelsson J et al. | Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability. | 2013 | Am. J. Physiol. Renal Physiol. | pmid:23657856 |
| Panizo S et al. | Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis. | 2013 | Nephrol. Dial. Transplant. | pmid:24013683 |
| Bellasi A et al. | Paricalcitol and cardiorenal outcome: from the IMPACT study to clinical practice. | 2013 | Blood Purif. | pmid:23736115 |
| Han T et al. | Meta-analysis: the efficacy and safety of paricalcitol for the treatment of secondary hyperparathyroidism and proteinuria in chronic kidney disease. | 2013 | Biomed Res Int | pmid:23509710 |
| Kim CS et al. | Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. | 2013 | PLoS ONE | pmid:23690997 |
Paricalcitol
Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.
Cross Reference
Introduction
To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Paricalcitol?
Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Paricalcitol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Paricalcitol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Paricalcitol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What genes are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.